07.28.25 -- CDMOs Should Stop Stringing Biotechs Along

To leverage the benefits of peptide therapeutics, identify an experienced chemical material manufacturer that can produce unique peptide building blocks with quality, efficiency, and continuous compliance.

Biopharmaceutical companies, to safeguard the consistent delivery of essential therapies to patients around the world alongside their CDMO partners, are rethinking traditional supply models.

Explore the pivotal advancements in ADCs that focus on high-DAR, multispecific designs, and novel payloads, while addressing challenges in manufacturability, scalability, and commercial viability.

Observe as Chief Editor Louis Garguilo opens the discussion with our panelists on the state of biologics outsourcing and the "must-haves" for sponsors of their CDMOs.

As timelines tighten and regulatory demands grow, discover how a European CDMO delivers integrated solutions from aseptic fill and finish to packaging and release.

Witness how we improved a client’s laboratory efficiency by transitioning temporary staff to full-time roles, enhancing morale, performance, and expanding their strategic partnership.

Identify and address potential anti-drug immune responses early in development to streamline your drug’s path to clinical success—start smart and finish fast.

ADCs have proven to be highly effective in cancer treatment, but their manufacturing poses challenges. Review how a CDMO partner can help bring these treatments to patients safely and efficiently.

KinetiSol enhances bioavailability of poorly soluble drugs like Vemurafenib by producing dense amorphous dispersions, outperforming traditional MBP methods in pharmacokinetics and dissolution.

Ensuring integrity in an increasingly complex pharmaceutical industry requires a holistic approach that incorporates quality control into all phases of product design and development.

Over the past 20 years, we have completed more than 175 successful projects around the globe, showcasing our commitment to quality and customer satisfaction.

Delve into how our expertise and advanced capabilities provide customized analytical solutions that ensure quality, precision, and regulatory compliance for your biotherapeutics.

We offer end-to-end microbial services, including cell line development, process development, scale-up, and both clinical and commercial GMP manufacturing services.

Review our comprehensive range of support services to streamline manufacturing processes, from product development to commercialization of aseptic and lyophilized products.